default search action
"In silico studies of natural product-like caffeine derivatives as ..."
Yassir Boulaamane et al. (2022)
- Yassir Boulaamane, Mahmoud A. A. Ibrahim, Mohammed-Reda Britel, Amal A. M. Maurady:
In silico studies of natural product-like caffeine derivatives as potential MAO-B inhibitors/AA2AR antagonists for the treatment of Parkinson's disease. J. Integr. Bioinform. 19(4) (2022)
manage site settings
To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.